| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 09/12/2007 | EP1832588A1 Condensed imidazole compound and use thereof |
| 09/12/2007 | EP1832575A1 Anti-inflammatory agents |
| 09/12/2007 | EP1832287A2 The use of anti-histaminics for acute reduction of elevated intracranial pressure |
| 09/12/2007 | EP1831226A2 CHIRAL FUSED 1,2 IMIDAZO 4,5-c RING COMPOUNDS |
| 09/12/2007 | EP1831225A2 Anti-inflammatory pyrazolopyrimidines |
| 09/12/2007 | EP1831224A2 Trycyclic heterocycles, their manufacture and use as pharmaceutical agents |
| 09/12/2007 | EP1830882A2 Process for the preparation of a boron-substituted porphyrin |
| 09/12/2007 | EP1830854A1 Arylpiperazine derivatives and use thereof as 5-ht1a receptor ligands |
| 09/12/2007 | EP1697366B1 6-(2-chloro-4-alkoxy-phenyl)-triazolopyrimidine, method for the production thereof and its utilization for controlling fungi and the agents contained therein |
| 09/12/2007 | EP1654263B1 Phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor |
| 09/12/2007 | EP1641797B1 4-(4-trans-hydroxycyclohexyl)amino-2-phenyl-7h-pyrrolo[2,3-d]pyrimidine hydrogen mesylate and its polymorphic forms |
| 09/12/2007 | EP1406616B1 Injectable galenic formulation for use in a diagnosis or a photodynamic therapy and method for preparing same |
| 09/12/2007 | EP0751926B1 Enhancement of the efficacy of drugs by deuteration |
| 09/12/2007 | CN101035800A Substituted azaporphyrins as fluorescence labels |
| 09/12/2007 | CN101035792A Novel diazabicyclic aryl derivatives and their medical use |
| 09/12/2007 | CN101035791A Pyrrolo[1,2-D][1,2-4]triazine as inhibitors of c-JUN N terminal kinases (JNK) and P-38 kinases |
| 09/12/2007 | CN101035790A (1S,5S)-3-(5,6-dichloropyridin-3-yl)-3,6-diazabicyclo[3.2.0]heptane benzenesulfonate |
| 09/12/2007 | CN101035789A (1S,5S)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane |
| 09/12/2007 | CN101033227A Pemetrexed ethylenediamine salt and preparation method thereof |
| 09/11/2007 | US7268232 Androgen receptor modulators and method of treating disease using the same |
| 09/11/2007 | US7268229 Such as acetoxymethyl diacetyl-coelenterazine, which is contacted with luciferase |
| 09/11/2007 | US7268146 (3,4-Dihydro-1H-isoquinolin-2-yl)-[2-methyl-7-(2,4,6-trimethyl-phenyl)-4,5,6,7-tetrahydro-2H-pyrazolo[3,4-b]pyridin-3-yl]-methanone; Corticotropin releasing factor (CRF); stress-related illnesses, mood disorders such as depression, major depressive disorder, single episode depression |
| 09/11/2007 | US7268138 Compounds, methods and pharmaceutical compositions for inhibiting PARP |
| 09/11/2007 | US7268136 Compositions useful as inhibitors of protein kinases |
| 09/11/2007 | US7268134 Medical devices employing triazine compounds and compositions thereof |
| 09/11/2007 | US7268133 Cannabinoid receptor ligands and uses thereof |
| 09/11/2007 | US7268128 Increase the intracellular cAMP level and further inhibit the activation of T cells; allergic diseases, inflammatory or immunological diseases |
| 09/11/2007 | US7268127 Azaindoles having serotonin receptor affinity |
| 09/11/2007 | US7268126 Polymorphic and amorphous forms of the phosphate salt of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6H-azepino[5,4,3-ce]indol-6-one |
| 09/11/2007 | US7267827 For therapy of inflammatory and pain of a traumatic or pathologic origin |
| 09/11/2007 | CA2429114C Treatment of premature ejaculation |
| 09/11/2007 | CA2373506C Process for manufacturing diazepine derivatives |
| 09/07/2007 | WO2007100990A2 Octahydro-pyrrolo[3,4-b] pyrrole derivatives and their use as histamine-3 receptor ligands |
| 09/07/2007 | WO2007100079A1 Prophylactic or therapeutic agent for allergic ophthalmic disease or allergic nasal disease comprising tricyclic triazolobenzoazepine derivative |
| 09/07/2007 | WO2007099171A2 Bicyclo-pyrazoles active as kinase inhibitors |
| 09/07/2007 | WO2007099092A1 SUBSTITUTED 6-PHENYL-7-AMINO[1,2,4]-TRIAZOLO[1,5-a]PYRIMIDINES AND THEIR USE FOR CONTROLLING PATHOGENIC FUNGI |
| 09/07/2007 | WO2007081991A9 Novel conjugated materials featuring proquinoidal units |
| 09/07/2007 | WO2007066200A3 Inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications |
| 09/07/2007 | CA2644810A1 Prophylactic or therapeutic agents for allergic ophthalmic diseases or allergic nasal diseases, comprising tricyclic triazolobenzazepine derivative |
| 09/07/2007 | CA2641624A1 Octahydro-pyrrolo[3,4-b] pyrrole derivatives and their use as histamine-3 receptor ligands |
| 09/06/2007 | US20070208071 Oxidative Degradation Products of Atorvastatin Calcium |
| 09/06/2007 | US20070208049 e.g. 1-(2,6-Difluorobenzyl)-5-(3-Mehthoxyphenyl)-6-Methyl-3-[N-Methyl -N -(2-Pyridylethyl)Aminoethyl]Uracil; anticarcinoganic agent; prostate cancer, benign prostatic hypertrophy, breast cancer and endometriosis |
| 09/06/2007 | US20070208046 such as 4-benzyloxy-1-{4-[2-(dimethylamino)ethoxy]phenyl}-1H-pyridin-2-one, that as antagonists to melanin concentrating hormone receptors, used for treating cardiovascular, nervous system, metabolic, reproductive system, respiratory system and gatrointestinal disorders |
| 09/06/2007 | US20070208044 Compounds and therapeutical use thereof |
| 09/06/2007 | US20070208038 6-(2-Fluorophenyl)-Triazolopyrimidines, Method for Producing Them, Their use for Controlling Parasitic Fungi and Agents Containing the Same |
| 09/06/2007 | US20070208037 Fungicidal 5-phenyl substituted 2-(cyanoamino) pyrimidines |
| 09/06/2007 | US20070208019 Vasculostatic agents and methods of use thereof |
| 09/06/2007 | US20070208013 Pyrrolotriazine Derivatives Useful For Treating Hyper-Proliferative Disorders And Diseases Associated With Angiogenesis |
| 09/06/2007 | US20070208010 {(1R)-1-(2,4,5-Trifluorobenzyl)-2-[9-(trifluoromethyl)-5,6-dihydrobis[1,2,4]triazolo[1,5-a:3',4'-c]pyrazin-3-yl]ethyl}amine, hydrochloride; metformin; treating non-insulin dependent (Type 2) diabetes in a mammal |
| 09/06/2007 | US20070208003 Compounds and methods for treating dyslipidemia |
| 09/06/2007 | US20070207995 Deazapurines useful as inhibitors of Janus kinases |
| 09/05/2007 | EP1829877A1 Bicyclic pyrrole derivatives |
| 09/05/2007 | EP1828200A1 Bi- and tricyclic substituted phenyl methanones as glycine transporter i (glyt-1) inhibitors for the treatment of alzheimer's disease. |
| 09/05/2007 | EP1828194A1 Tetracyclic imidazo-benzodiazepines as gaba receptors modulators |
| 09/05/2007 | EP1828193A1 Pyridil-substituted spiro-hydantoin compounds and use thereof |
| 09/05/2007 | EP1828192A2 Dipeptidyl peptidase inhibitors |
| 09/05/2007 | EP1828191A2 7-amino-6-hetaryl-1,2,4-triazolo[1,5-a]pyrimidine compounds and the use thereof for controlling pathogenic fungi |
| 09/05/2007 | EP1828190A1 7-amino-6-heteroaryl-1,2,4-triazoloý1,5-a¨pyrimidines and to the use thereof for combating pathogenic fungi |
| 09/05/2007 | EP1828186A1 Pyrido pyrimidinones, dihydro pyrimido pyrimidinones and pteridinones useful as raf kinase inhibitors |
| 09/05/2007 | EP1480032B1 Reagent for determining the absolute configuration of chiral compound and determination method |
| 09/05/2007 | EP1373233B1 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same |
| 09/05/2007 | CN101031570A Inhibitors of vegf receptor and hgf receptor signaling |
| 09/05/2007 | CN101031569A Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta |
| 09/05/2007 | CN101031567A Novel piperidin-4-yl-thiazole-carboxamide analogues as inhibitors of t-cell proliferation and uses thereof |
| 09/05/2007 | CN101031539A Substituted arylalkanoic acid derivatives and use thereof |
| 09/05/2007 | CN100335483C Double piperazine quaternary ammonium salt compound with analgetic function |
| 09/04/2007 | US7265378 Light emitting diodes |
| 09/04/2007 | US7265225 For therapy of cancer |
| 09/04/2007 | US7265221 Pyrrolo[2,3-d]pyrimidine compounds |
| 09/04/2007 | US7265132 Peptidyl spiroheterocyclic, amidino and guanidino compounds; reversible inhibitors of the cysteine protease cathepsin S, K, F, L and B; useful in the treatment of autoimmune and other related diseases |
| 09/04/2007 | US7265129 Anti-infective biaryl compounds |
| 09/04/2007 | US7265124 Cristalline and amorphous form of a triazolo (4,5-D) pyridimine compound |
| 09/04/2007 | US7265120 Pyrazine derivatives and pharmaceutical use thereof |
| 09/04/2007 | US7265119 For therapy of nicotine dependency |
| 09/04/2007 | US7265115 Central nervous system-active cholinergic ligands for neuronal nicotinic receptors; Controlling synaptic transmission; selectively controlling neurotransmitter release; a (halopyridazinyl)-3,8-diazabicyclo(3.2.1)octane |
| 09/04/2007 | US7265114 Antiproliferative agents for smooth muscle cells; antiinflammatory agents for endothelial cells; restenosis, atherosclerosis |
| 09/04/2007 | US7265113 Anticancer agents; antiinflammatory agents, for therapy of rheumatoid arthritis |
| 09/04/2007 | US7265105 Pyrrolobenzodiazepines |
| 09/04/2007 | US7265104 Tetraazabenzo[e]azulene derivatives and analogs thereof |
| 09/04/2007 | US7265100 Separation of regioisomers of metal phthalocyanines |
| 09/04/2007 | CA2413761C A process for preparing pyrazolopyrimidinone derivatives for the treatment of impotence |
| 09/04/2007 | CA2271861C Heterocyclic metallocenes and polymerization catalysts |
| 08/30/2007 | WO2007097937A1 Pyrrolidine derivatives as erk inhibitors |
| 08/30/2007 | WO2007097470A2 Fused nitrogen- comprising heterocyclic compound |
| 08/30/2007 | WO2007097197A1 Amide derivative or salt thereof |
| 08/30/2007 | WO2007096807A2 Process for the preparation of zaleplon and an intermediate thereof |
| 08/30/2007 | WO2007096588A1 Salt of cd 80 antagonist |
| 08/30/2007 | WO2007096334A1 Pyrrolopyrrolones active as kinase inhibitors |
| 08/30/2007 | WO2007095828A1 Dihydroporphine e6 zinc complexes as photosensitizer, their preparation and their use |
| 08/30/2007 | WO2007079163A3 Prokineticin 1 receptor antagonists |
| 08/30/2007 | WO2007034326A3 Imidazole compounds for the treatment of neurological disorders |
| 08/30/2007 | WO2006087120A8 Pyrazolopyrimidines |
| 08/30/2007 | US20070203340 Process for preparing substituted 5-amino-pyrazolo-[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines |
| 08/30/2007 | US20070203338 2-((4,6-dimethoxy)pyrimidin-2-yl-),3-(methoxy-), 3,3-(diphenyl)propionic acid; antihypotensive agents; pulmonary hypertension, mycocardial necrosis; renal failure; brain disorders; antispasmodic agents; antiischemic agents; coagulants; asthma; atherosclerosis; restenosis; Raynaud's syndrome |
| 08/30/2007 | US20070203219 Crystalline 7-methoxycarbonyl-9-(methoxycarbonylmethyl)-3-[(tetrahydro-2H-pyran-2-yl)oxy]-9-azabicyclo[3.3.1]nonane |
| 08/30/2007 | US20070203187 Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof |
| 08/30/2007 | US20070203160 p38 MAP kinase inhibitors and methods for using the same |
| 08/30/2007 | US20070203159 Purine compounds |
| 08/30/2007 | US20070203157 inhibitors of potassium channel function; to treat arrhythmia; 7-(3,4-Dichlorophenyl)-6-(4-fluorophenylsulfonyl)-2,5-dimethyl-4,7-dihydropyrazolo[1,5-a]pyrimidine |
| 08/30/2007 | US20070203145 Zopiclone resolution |